


Avenio AI is a technology company purpose-built for pharmaceutical, biotech, and clinical research organizations. Our flagship product, the Intelligent Protocol Hub, uses advanced AI and machine learning to automate and streamline the end-to-end clinical protocol development process — from initial design through compliance validation. The Intelligent Protocol Hub empowers study teams to design smarter protocols faster, reduce regulatory risk, and accelerate study startup timelines. By unifying structured and unstructured clinical data, the platform surfaces real-time risk identification, supports protocol authoring with AI-driven recommendations, and ensures alignment with regulatory and compliance standards from day one. Avenio AI is trusted by clinical research and drug development teams who need to move from concept to trial-ready protocol with greater speed, consistency, and confidence